New insider activity at PepGen Inc. ( (PEPG) ) has taken place on October 1, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Oxford Sciences Innovation plc, a former 10% owner, has made a significant investment by purchasing 200,000 shares of PepGen Inc. stock, valued at $640,000.
Recent Updates on PEPG stock
PepGen Inc. has recently seen significant developments impacting its stock performance. The company updated its corporate presentation, emphasizing the potential of its investigational therapy PGN-EDODM1 for Myotonic Dystrophy Type 1, which has shown a favorable safety profile and significant splicing correction. This announcement, coupled with its designation as an Orphan Drug in the U.S. and EU, highlights PepGen’s strategic positioning in the biotech industry. Analysts have raised the price target for PepGen’s stock, driven by promising trial results from the FREEDOM-DM1 Phase 1 study, which demonstrated a substantial improvement in splicing correction at higher doses. Additionally, RA Capital’s increased stake in the company and a successful public offering have provided financial backing for ongoing research and trials. Despite these positive developments, financial challenges remain, with limited revenue and continued losses affecting the overall valuation. Nevertheless, these advancements have led to a 3% increase in PepGen’s stock price afterhours.
Spark’s Take on PEPG Stock
According to Spark, TipRanks’ AI Analyst, PEPG is a Underperform.
PepGen Inc.’s overall score reflects significant financial challenges, with limited revenue and continued losses. While technical indicators are mixed, the valuation remains unattractive due to negative earnings. Recent corporate events, including promising trial results and board expansions, offer some positive momentum but are insufficient to offset the financial concerns.
To see Spark’s full report on PEPG stock, click here.
More about PepGen Inc.
YTD Price Performance: 22.55%
Average Trading Volume: 3,116,046
Technical Sentiment Signal: Buy
Current Market Cap: $297.2M